• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Top Recommended Veterinary Products
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Update on fluid therapy in horses (Proceedings)

August 1, 2010
K. Gary Magdesian, DVM, DACVIM, DACVECC, DACVCP, CVA

In general, sufficient fluids have been given when the horse/foal begins to pass urine.

Fluid Plans

     •Replacement: Determining Rate

     • New : 'Fluid Challenge' Method:

     • Volumes are based on "fluid challenges" rather 'estimates' of deficits

     • Traditional method is with estimates of % of water loss

          o Riddled with errors....

"Fluid Challenge Method"

     • 20 mL/kg boluses of isotonic crystalloid over 30-60 minutes, then reassess for more

          o Repeat boluses until signs of shock abate or plateau, or until limits reached, indicating the need for vasopressors

          o 10 L for an average adult horse

          o 1 L for average neonatal foal

Fluid Challenge for Colloids

     • Lower rates because they stay within the vascular space

          o 3-10 mL/kg hetastarch

How much to give?

Base it on Clinical response

     • Mentation

          o Increase alertness

          o Foal that is kicking is rarely severely hypovolemic

     • Urination

          o In general, sufficient fluids have been given when the horse/foal begins to pass urine

     • Decrease heart rate

     • Improvement in membrane color or capillary refill

     • In hospital= blood pressure (> 60 mmHg in foal, 80 in adult)

Crystalloids vs. Colloids?

     • Crystalloids only contain electrolytes or glucose in water

     • Colloids contain large MW particles

          o Proteins or synthetic polysaccharides

     • Human studies fail to show an advantage of 1 over the other

          o Use together may be ideal

     • Isotonic crystalloids hydrate entire ECF

          o 25 % to plasma volume; 75 % to interstitium

     • Colloids expand the intravascular space only

     • Rapid expansion of plasma volume

     • Large particles stay within vessels

     • Colloids are better in horses concurrently hypovolemic and hypooncotic

Replacement Crystalloids

     • Choices:

          o Lactated Ringer's Solution (LRS)

          o Normosol-R

          o Plasma-Lyte 148 or A

          o Normal saline (0.9%)

Isotonic Crystalloids

LRS

     • Contains calcium

          o Not ideal when using blood products, sodium bicarbonate

     • Contains lactate

     • Contains potassium (4 mEq/L)

     • Chloride is relatively high (109 mEq/L) relative to sodium (130)

          o Na-Cl difference is 21 (ref: 40) – making this acidifying

     • Clinical Uses:

Advertisement

          o Botulism

          o Endurance horses

     • Do not use in:

          o Oleander cases

          o Not ideal in liver failure cases

Isotonic Crystalloids

Normosol R / PlasmaLyte 148 / PlasmaLyte A

     • Contain magnesium (3 mEq/L)– no calcium

     • Contain acetate/gluconate – no lactate

     • Contain potassium (5 mEq/L)

     • Sodium-chloride difference is optimal

          o Na=140

          o Cl=98

     • Can use with HCO3 or PO4 or blood products

     • Clinical Uses:

          o Oleander and arrhythmia cases

          o Brain injury cases

          o Liver failure cases

     • Do not use:

          o Botulism cases

Isotonic Crystalloids

Physiologic saline (0.9 %)

     • Contains only sodium and chloride

     • Compatible with blood products, sodium bicarbonate

     • No potassium

     • Increases chloride concentration relative to sodium concentrations in equine plasma

          o Mildly acidifying due to relative increase in chloride

Equine Plasma      Saline

Na = 130-140 mEq/L      154 mEq/L

Cl = 90-100 mEq/L      154 mEq/L

Normal Saline

Clinical Uses:

     • Do not use in acidemic cases

     • Not optimal fluid for most cases, although can be used

     • Good where potassium is not desirable

          o HYPP

          o Ruptured bladder

     • Good for hypochloremic cases with alkalosis

          o Some rhabdomyolysis cases

          o Endurance horses not heavily supplemented

Colloids

Solutions containing large molecular weight (> 5000 Da) proteins or polysaccharides

Colloid Choices

     • Natural colloids

          o Plasma

          o Whole blood

     • Synthetic colloids

          o Hetastarch

          o Dextrans

Indications for Colloids

Hypovolemia with concurrent hypoproteinemia

     • Examples:

          o Colitis

          o Lawsonia foals

     • Crystalloids distribute among the entire ECF potentiating edema

     • Colloids are restricted to the intravascular space, (assuming endothelial integrity)

          o Less likely to cause edema

Hetastarch

     • Large molecular weight synthetic pss in solution

     • May have advantages over plasma during endotoxemia or sepsis with endothelial compromise

          o Fraction with MW > 100,000 may be retained within vessels

          o Smaller fractions and albumin may extravasate

     • More cost effective than plasma on a per unit oncotic pressure basis

Hetastarch - Adverse Effects

Dose-dependent hemostatic alterations

     • Induces a von Willebrand like state

          o Prolongation of PT and PTT

     • Coats platelet surface

          o Alters platelet function

     • May not want to use in pre-surgical case

     • Don't use in bleeding cases

Hetastarch Doses

Suggested doses

     • 10 mL/kg/day

          o Safe, but do not exceed

Plasma

     • Great colloid for foals

     • Has antibodies for FPT, R. equi, other diseases

     • Has clotting factors, antithrombin

     • 40 ml/kg for foals whenever possible for FPT

          o (2 L for average sized foal)

     • Adult horses 2-3 L

Hypertonic Saline (7 %)

     • Sodium: 1200 mEq/L

     • Chloride: 1200 mEq/L

     • Dose: Small volumes = 4 mL/kg

     • Rapid, transient plasma volume expansion

          o Borrows' water temporarily – increases blood volume and CO transiently

          o Shifts water from interstitium and ICF until osmolarity equilibrates

Advantages

     • Other potential advantages:

          o Improvement in cardiac contractility (CO)

          o Antiinflammatory

          o Reduces endothelial and RBC edema Reduces neutrophil activation and endothelial adhesion

          o Neurologic – reduces glutamate release, decreases intracellular calcium accumulation

Potential Adverse Effects of HS

     • Potential adverse effects:

          o Hypernatremia and hyperosmolarity

Contraindications

     • Severe dehydration (8-10 %) – no water to borrow

          o Provide initial isotonic fluids, then follow with HS

     • Judicious use in the neonatal foal

     • Uncontrolled hemorrhage – may cause more bleeding

Additives

     • Potassium

     • Calcium

     • Magnesium

     • Phosphorus

Potassium

     • Hypokalemia most common

          o Anorexia

          o Diuresis

          o Stress (excess corticosteroids and aldosterone)

          o Loss in diarrhea

Treat

     • Empiric supplementation:

          o If K < 2.7 add 40 mEq/L KCl or KPO4

          o If K 2.8-3.3 add 20 mEq/L KCl or KPO4

          o If K 3.4-3.5 add 10 mEq/L KCL or KPO4

          o Maximum: 0.5 mEq/kg/h

Hypokalemia

     • Oral supplementation:

          o g/kg KCl per day, divided into 4 treatments per day

     • If hypokalemia is refactory to treatment:

          o Supplement with magnesium

3 mEq/L MgSO4

Calcium

     • Ionized Hypocalcemia

          o Anorexia

          o Loss in sweat (endurance horse)

          o Parathyroid dysregulation (endotoxemia, SIRS)

     • Treat: < 1.1 mmol/L (4.4 g/dL)

     • Treat: 0.5-1 mEq/kg 23% calcium gluconate

          o Slow, dilute

          o If refractory: supplement with magnesium

Magnesium

     • Hypomagnesemia

          o Anorexia

          o GI disease, ileus

          o Diuresis – most fluids are devoid of Mg

          o Excessive sweating

          o Treat: 3 mEq/L (up to 10 mEq/L)

          o Normosol and PlasmaLyte contain this amount

          o Provides 3 mEq/L, or 30 mg/dL of MgCl2

          o If clinical signs present: 8-32 mg/kg, not to exceed 50 mg/kg at 2 mg/kg/min

Phosphorus

     • Not routinely supplemented unless hypophosphatemic or anorexic for > 1-2 d

          o mmol/kg/h of sodium (or potassium) phosphate, administered for 8-24 h per day as needed

          o Requirement: 28 mg/kg orally

     › 35 % absorption efficiency:

     › Translates to 10 mg/kg/d IV requirement

     › 0.013 mmol/kg/h

Related Content:

Equine Medicine
CBD provides one mustang with a second chance
CBD provides one mustang with a second chance
Updated EquiTrace app integrates wth HISA Portal
Updated EquiTrace app integrates wth HISA Portal
SoCal Equine Hospital installs innovative CT scanner
SoCal Equine Hospital installs innovative CT scanner

Advertisement

Latest News

To refer or to not refer

Advice panel for women interested in the veterinary field

AVMA president set to testify before Congress

New Hawaii-based pet CBD brand launches

View More Latest News
Advertisement